Department of Otolaryngology, Division of Facial Plastic and Reconstructive Surgery, Loma Linda University Health, Loma Linda, California, USA.
Curr Opin Otolaryngol Head Neck Surg. 2021 Aug 1;29(4):265-270. doi: 10.1097/MOO.0000000000000727.
To explore recent advances in therapeutic interventions for nonflaccid facial paralysis (NFFP), including new evidence for surgical and nonsurgical treatments. Timing of treatment is also discussed, along with possible future treatments.
NFFP remains a difficult disease to treat. Chemodenervation with botulinum toxin remains a first-line treatment to suppress aberrant and antagonistic movements during voluntary use of muscles. More permanent treatments such as selective neurectomy, myectomy, and nerve and muscle transfers have been shown to offer promising results for the nonflaccidly paralyzed face.
NFFP is commonly seen in patients who have incomplete recovery from facial paralysis, and carries high psychosocial morbidity. A large array of treatments have been described in the literature, both procedural and nonprocedural. Both treatment type and timing are important in optimal patient recovery.
探讨非弛缓性面瘫（NFFP）治疗干预措施的最新进展，包括手术和非手术治疗的新证据。还讨论了治疗时机以及可能的未来治疗方法。
NFFP 仍然是一种难以治疗的疾病。肉毒毒素化学神经切断术仍然是治疗因肌肉自愿使用而导致的异常和拮抗运动的一线治疗方法。选择性神经切除术、肌切除术以及神经和肌肉转移等更永久性的治疗方法已被证明可为非弛缓性瘫痪的面部提供有希望的结果。
NFFP 常见于面瘫恢复不完全的患者，具有较高的社会心理发病率。文献中描述了大量的治疗方法，包括手术和非手术方法。治疗类型和时机对患者的最佳康复都很重要。
